AISHA HAVILL: Open Payments
NPI 1235779620 · SEBREE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 40 payments from 11 companies in 2025. Trend: 2023 $864 · 2024 $1,240 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $184 |
| Axsome Therapeutics, Inc. | 10 | $101 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Indivior Inc. | 2 | $44 |
| PFIZER INC. | 2 | $37 |
| Alkermes, Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
Products named: VRAYLAR, HETLIOZ, Auvelity, MAVYRET, SUBLOCADE, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
